[1]Brenner H,Kloor M,Pox CP.Colorectal cancer［J］.Lancet,2014,383(9927):1490-1502.
[2]Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics,2002［J］.CA Cancer J Clin,2005,55(2):74-108.
[3]Fong Y,Fortner J,Sun RL,et al.Clinical seore for predieting recurrence after hepatic resection for metastatiec corcetal cancer:Analysis of 1001 consecutive cases［J］.Ann Surg,1999,230(3):309-321.
[4]Masi G,Loupakis F,Pollina L,et al.Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin,oxaliplafin,and irinotecan(FOLFOXIRI) followed by radical surgery of metastases［J］.Ann Surg,2009,249:420-425.
[5]Gravalos C,Garcia-Escobar I,Garcia-Alfonso P,et al.Adjuvant chemotherapy for stages Ⅱ,Ⅲ and Ⅳ of coloncancer［J］.Clin Transl Oncol,2009,11:526-533.
[6]Eriguehi M,Osada I,Fujii Y,et al.Pilot Study for preoper ative administration of L-OHP to patients with advaneed seirrhous type gastric cancer［J］.Biomed Pharmaeother,1997,51(5):217-220.
[7]Cortejoso L,Lopez-Fernandez LA.Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients［J］.Pharnacogenomics,2012,13(10):1173-1191.
[8]Jiang XM,Peng JW,Xiao JJ.Systematic efficacy evaluation of xeloda in combination with oxaliplatin in the treatment of metastatic colorectal cancer［J］.Practical Cancer,2014,29(7):756-759.［江小梅，彭杰文，萧剑军．希罗达联合奥沙利铂治疗转移性结直肠癌的疗效系统评价［J］．实用癌症杂志，2014,29(7):756-759.］
[9]Jean-Nicolas Vauthey,Timothy M Pawlik,Dario Ribero,et al.Chemotherapy regimen prediets steatohepatitis and an increase in 90-cay mortality after surgery for hepatic colorectal metastases［J］.J Clin Oncol,2006,24(13):2065-2072.
[10]Yan YL,Mo YS,Zhang DM.Preventive action of magnesium isoglycyrrhizinate in liver damage induced by chemotherapy in initial treatment of patients with gastrointestinal cancer［J］.Chin J Hepatol,2015，23（3）：204-208.［闫玉兰，莫永森，张冬梅.异甘草酸镁对化疗药物致初治胃肠道肿瘤患者肝损害的预防作用［J］.中华肝脏病杂志，2015，23（3）：204-208.］
[11]Nie Y.Clinical observation of magnesium isoglycyrrhizinate injection on treatment of serious hepatitis ［J］.Drugs and Clinic,2014,29(1):55.［聂燕．异甘草酸镁注射液治疗重症肝炎的疗效观察［J］．现代药物与临床，2014,29(1):55.］
[12]Zhao RM,Zhang ZQ,Li B.The curative effect observation of magnesium isoglycyrrhizinate injection in the treatment of severe hepatitis［J］.China Practical Medcine,2015,10(21):166-167.［赵瑞敏，张志强，李波．重症肝炎采用异甘草酸镁注射液治疗的临床观察［J］．中国实用医药，2015,10(21):166-167.］
[13]Velmurugan B,Gangar SC,Kaur M.Silibinin exert sustained growth suppressive effect against human colon carcinoma SW480 xenograft by targeting multiple signaling molecules［J］.Pharm Res,2010,27(10):2085-2097.
[14]Moertel CG,Fleming TR,Macdonald JS,et al.Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma［J］.N Engl J Med,1990,322:352-358.
[15]Abbou DG,Kaplowitz N.Drug induced liver injury［J］.Drug Saf,2007,30(4）：277-294.
[16]Rubbia-Brandt L,Audard V,Sattoretti P,et al.Severe hepatic sinuaoidal obstruction associated with metastatic colorectal cancer［J］.Ann Oncol,2004,15:460-466.
[17]Aloia T,Sebagh M,Plasse M,et al.Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatinin colorectal cancer liver metastases［J］.J Clin Oncol,2006,24:4983-4990.
[18]Zhang Qing，Fan Lin，Cui Haiyan.Analysis on treatment outcome of bicyclol in preventing antituberculosis drug-induced liver injury［J］.Capital Medicine,2011,4:26.［张青，范林，崔海燕.双环醇片预防抗结核药物所致肝损害的疗效分析［J］.首都医药，2011,4:26.］
[19]Bai XR,Chen J,Qu QF，et al．Observation of the efficacy in 40 cases of bicyclol combine with metformin treatment of fatty liver ［J］.J Clin Hepatol,2010,26(3):288-289.［白晓茹，陈吉，瞿启芬，等.双环醇联合二甲双胍治疗脂肪肝40例疗效观察［J］.临床肝胆病杂志，2010,26(3):288-289.］
[20]Liu GT,Zhang CZ,Li Y,et al.The study of bicyclic alcoho which is a kind of new anti-hepatitis drug［J］.J Med Res,2010,39(7):1-2.［刘耕陶，张纯贞，李燕，等.抗肝炎新药双环醇的研究［J].医学研究杂志,2010,39(7):1-2.］
[21]Pan SY,Zhou SF,Gao SH,et al.New perspectives on how to discover drugs from herbal medicines:CAM 's outstanding contribution to modern theraperutics ［J］.Evid Based Complement Alternal Med,2013,2013:627375.
[22]Gu X,Dong LP,Liu YC,et al．Study of isoglycyrrhizinate magnesium's protective effect on liver injury in mice caused by cute carbon tetrachloride［J］.Chin Pharmacists,2009,12(1):37-39.［顾新，董丽萍，刘宇宸，等．异甘草酸镁对急性四氯化碳肝损伤小鼠保护作用的研究［J］.中国药师，2009，12(1）：37-39.］
[23]Chen WH,Lu LG,Zeng MD,et al．Effect of magnesium isoglycyrrhizinate on proliferation and oxidative stress of hepatic stellate cell in mice［J］.Chin J Hepatol,2006,14(6):426-430.［陈尉华，陆伦根，曾民德，等．异甘草酸镁对大鼠肝星状细胞增殖和氧应激的影响［J］.中华肝脏病杂志，2006，14(6):426-430.］
[24]Xu ZN,Wu XM,Wang P,et al．Therapeutic effect of 18-α glycyrrhizin on chronic liver injury in mice caused by carbon tetrachloride［J］.J Practical Clin Med,2011,15(21):1-4.［徐中南，吴锡铭，王佩，等.18-α 甘草酸对大鼠四氯化碳慢性肝损伤的治疗作用［J］.实用临床医药杂志，2011,15(21）：1-4.］
[25]Cheng Y，Zhang J，Shang J，et al．Prevention of free fatty acid-induced hepatic lipotoxicity in HepG2 cells by magnesium isoglycyrrhizinate in vitro［J］.Pharmacology，2009，84(3）：183-190.
[26]Ramhaldi A，Gluud C．Propylthiouracil for alcoholic liver disease［J］.Cochrane Database Syst Rev，2005，19(4):2800.
[27]Hu HI,Cheng RD,Ma LH,et al.Peroxidation mechanism and protective effect of zine on D-galactosamine induced liver injury in rats［J］.Chin J Pharmcol and Toxicol,1993,7(1):81.
[28]Zhao H,Chen WP,Guo JC,et al．Determination and clinical significance of glutathione levels in blood of patients with chronic hepatitis B［J］.Hepatology,2000,5(4):207.［赵灏,陈伟平,郭建春,等.慢性乙型肝炎病人血液中谷胱甘肽水平的测定及其临床意义［J］.肝脏,2000,5(4)：207.］